DeepCurrents Investment Group’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

DeepCurrents Investment Group’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,730	Closed	-$179K	–	196
2022 Q4	$179K	Hold	17,730	–	–	0.01%	160
2022 Q3	$176K	Buy	+17,730	New	+$175K	0.01%	179
2022 Q2	–	Sell	-17,730	Closed	-$175K	–	251
2022 Q1	$175K	Hold	17,730	–	–	0.01%	162
2021 Q4	$174K	Buy	+17,730	New	+$174K	0.01%	156

DeepCurrents Investment Group's BIOT Position: Q1 2023 in Review

DeepCurrents Investment Group sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 17,730 shares — an estimated $179K sold.

DeepCurrents Investment Group first reported a position in BIOT in Q4 2021 and held it in 4 quarters. The position peaked at $179K in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

DeepCurrents Investment Group reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
DeepCurrents Investment Group sold 17,730 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $179K.
DeepCurrents Investment Group first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q4 2021 and held it in 4 quarters.
DeepCurrents Investment Group's Biotech Acquisition Company Class A Ordinary Shares position peaked at $179K in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on DeepCurrents Investment Group's 13F filing for Q1 2023, filed 15 May 2023.